Wed, Jan 28, 2015, 2:42 PM EST - U.S. Markets close in 1 hr 18 mins

Recent

% | $
Quotes you view appear here for quick access.

Kinder Morgan Energy Partners, L.P. Message Board

jad9000 401 posts  |  Last Activity: 2 hours 7 minutes ago Member since: Nov 3, 2004
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    I'll ask yet again...

    by durrett.scott Oct 27, 2014 4:47 PM
    jad9000 jad9000 Oct 28, 2014 6:52 PM Flag

    Hillary Clinton is a lousy campaigner and it shows. She is thin skinned, arrogant and has proven to be a lousy manager. What job has she ever had where she learned to manage anything? Answer - zero. The report just produced by the Inspector General says a lot:
    "The State Department's Office of Inspector General has released another “management alert” detailing rampant mismanagement within the agency, much of it during Secretary of State Hillary Clinton's tenure.
    The inspector general’s latest “management alert” — the third released by the agency's internal watchdog in a little over a year — warns that the State Department’s management and oversight of grants has become a serious financial liability.
    “The management and oversight of grants poses heightened financial risk to the Department of State,” Inspector General Steve A. Linick said in a report dated Sept. 26 but released Sept. 30.
    Linick became the agency’s inspector general in September 2013, ending a vacancy that had lasted nearly six years.
    After Linick assumed the role, he almost immediately issued two "management alerts." The latest alert in September marks the third of its kind in the IG’s history. Each alert issued by Linick has related to issues that festered and went unaddressed during Hillary Clinton’s tenure."

    Sentiment: Strong Buy

  • Reply to

    Confused Hilary On The Campaign Trail

    by fred357mag2000 Oct 26, 2014 7:27 AM
    jad9000 jad9000 Oct 28, 2014 7:19 PM Flag

    Hillary may well not run. She cannot take the heat of constantly being questioned, constantly having her ineptitude tossed in her face, constantly being on the road with late nights and early mornings, constant pressure from donors, constant questions about the Clinton Foundation finances and donors, never ending questions about her Wall Street ties, etc. She also is subject to blood clots, which she has had, and is still on blood thinners. I do not she is physically up to the campaign or the job and may well bow out after the first of the year.

    Sentiment: Strong Buy

  • Reply to

    Confused Hilary On The Campaign Trail

    by fred357mag2000 Oct 26, 2014 7:27 AM
    jad9000 jad9000 Oct 28, 2014 8:37 PM Flag

    TicTocTicToc - another week and you and yours are banished to the bowels of nowhere. Dems will lose the Senate, Hillary will likely not run or if she tries, won't win. Elizabeth Warren is already crawling up her rear politically and i afar better candidate for the far left . She will continue to make gaffs trying to teeter totter between the far left and Wall street money. She is now under 50% in favorable ratings and will stay below that level. The money and status is ultimately more important than the office. She'll take the money, the private jets and the status - mostly the money. Remember, per her comment, she's not "really" rich. And, of course, "business doesn't create jobs". No amount of reinterpreting her nutty comments will make the comments go away. "Why does it matter". She's about to find out just how much it matters - Clyde. So, bend over and kiss your rosey red eye goodbye for the next decade or so.

    Sentiment: Strong Buy

  • Reply to

    AGNC book value falls about 3%

    by chuck_960 Oct 27, 2014 5:51 PM
    jad9000 jad9000 Oct 29, 2014 8:34 AM Flag

    And now with the huge decline in rates it is likely up 4% to 5%. Rates are going nowhere for years, leverage will be increased, they will go farther out on the curve, spreads will increase, net interest income will vault, BV will rise as loss carry forward is displaced with profits - driving it up, hedges will be pulled back. etc. Q4 will be a huge winner as well all of next year.

    Sentiment: Strong Buy

  • Reply to

    Newest short interest report.....

    by insmhistorian Oct 24, 2014 5:30 PM
    jad9000 jad9000 Oct 29, 2014 3:31 PM Flag

    Well, contact Wikipedia and tell them they need to correct their definitions and explanations.

    Sentiment: Strong Buy

  • Reply to

    How long a delay

    by terry_insm May 20, 2014 6:28 PM
    jad9000 jad9000 Oct 29, 2014 7:30 PM Flag

    the king of the clowns is talking about clowns. Go away moron.

    Sentiment: Strong Buy

  • jad9000 jad9000 Oct 29, 2014 7:34 PM Flag

    You mean Terry/ terry_insm/kim_philbee/newagebios/kvmncdd/eastofhgwy1/winkiechantwhenistudy
    He's a schizo moron that is drowning in his own stupidity. Back your rubber room Terry and shack up with your fake ids and Barbie dolls.

    Sentiment: Strong Buy

  • jad9000 jad9000 Oct 29, 2014 8:54 PM Flag

    I think it's because of the language of the settlement that makes them extremely careful about what they say. They have better hings to do than spend time and money on lawyers. FYI, the IR person is unresponsive and worthless to retail investors.

    Sentiment: Strong Buy

  • jad9000 jad9000 Oct 29, 2014 8:55 PM Flag

    They botched the clinical regarding endpoints. Sound familiar?

    Sentiment: Strong Buy

  • Reply to

    Shire

    by lux19insm Oct 28, 2014 9:24 PM
    jad9000 jad9000 Oct 30, 2014 8:44 AM Flag

    The natural partner for Insmed is Shire for development of Iplex. They are moving toward commercialization of Iplex, which includes production. They will have completed Phase II and likely Phase III by the time the patents are no longer valid for Increlex. I suspect they have also looked at lots of other potential uses once they are actively in market with Premiplex. Insmed can move right into the production schedule at that point without trial or investment regarding short stature ($250 million market) and partner with Shire in many other markets. Win-win for both companies.

    Sentiment: Strong Buy

  • Reply to

    Shire

    by lux19insm Oct 28, 2014 9:24 PM
    jad9000 jad9000 Oct 30, 2014 9:33 AM Flag

    I also remember that Insmed was talking about relocating their headquarters to Ireland (I think) for tax purposes. As all of their business for a while will not be in the US and manufacturing will be in Canada a tie up in some way with Shire makes even more sense. The sooner something like this happens the better for them. These new government rules regarding businesses leaving the country are becoming costly - especially if they start generating revenues this year. At a minimum, setting up an EU subsidiary, ala Apple, makes sense and with an EU company as a partner even more sense..

    Sentiment: Strong Buy

  • Terry, the schizo moron who is universally despised for his dozens of fake ids, never ending blathering and psychotic behavior just won't leave the board - eve though he stated just a while ago he was leaving forever. His new handle is now terry_insm/kim_philbee/newagebios/kvmncdd/eastofhgwy1/winkiechantwhenistudy.. I'll keep adding as he wheels out more fake ids.

    Sentiment: Strong Buy

  • Terry, aka terry_insm/kim_philbee/newagebios/kvmncdd/eastofhgwy1/winkiechantwhenistudy is a blathering moron who's opinion is worthless, as is the opinion of the dozens of fake Ids he uses to support his lunatic rants. Back to your rubber room freak.

    Sentiment: Strong Buy

  • Reply to

    Iplex

    by bohemianclubman Oct 30, 2014 11:20 AM
    jad9000 jad9000 Oct 30, 2014 12:00 PM Flag

    Pretty simple. Let the Premacure folks burn up $50 to $60 million in cash getting positioned to go to market and taking on the risk. Then all the work is done. Then, ride the out sourced manufacturing that is put into place by Shire and take over the short stature marketplace. Along the way, keep signing developmental partnerships for other indications. Short stature alone, given the known pipeline, adds $1.5 billion to their market value ($250 million x the average revenue to valuation multiple of 6x for biotechs). They gave up potential $500 million in sales for ROP as a trade off for letting someone else do all the work and spend all the money - which they will in turn leverage to far greater revenues and valuation.

    Sentiment: Strong Buy

  • jad9000 jad9000 Oct 30, 2014 12:04 PM Flag

    He's an illiterate, illegal and schizophrenic freak show that should be in a locked cell with padded wall - back in the third world hole he crawled out of. Hopefully when they come to get him he'll be able to take his fake Ids and Barbie doll wives with him.

    Sentiment: Strong Buy

  • The clown show continues spouting gibberish while he plays with his fake Ids and Barbie doll wives. Back to your rubber room Terry - while you wait for ICE to come get you.

    Sentiment: Strong Buy

  • jad9000 jad9000 Oct 30, 2014 1:09 PM Flag

    From out of the rubber room comes another ignorant comment from you terry,who would`ve thought? Don`t you get the fact that there`s not one person here who cares what you write because they`re all lies? Your a short and we all know it,meaning you`re a liar and a fraud,and all your posts are designed to confuse and distract from the facts,so as you think,will help your short position,sorry to tell you your time is severely wasted,but obviously that doesn't bother someone who`s insane like you. - blueyedcatch

    Sentiment: Strong Buy

  • jad9000 jad9000 Oct 30, 2014 8:55 PM Flag

    Terry is getting desperate as his entire life is wrapped up a schizophrenic fog. He and his fake ids, terry_insm/kim_philbee/newagebios/kvmncdd/eastofhgwy1/winkiechantwhenistudy have now been outed as someone who's opinion is worthless, as is the opinion of the dozens of fake Ids he uses to support his lunatic rants. The board has had enough of him and there is nowhere to hide - except in his rubber room.

    Sentiment: Strong Buy

  • jad9000 jad9000 Oct 30, 2014 9:10 PM Flag

    The Tercica/Increlex patent expires in October, 2017. (INCRELEX®MECASERMIN RECOMBINANT 2017-09) At this point Insmed can take over the pipeline they built and eventually abandoned because their product sucked.

    Sentiment: Strong Buy

  • jad9000 jad9000 Oct 30, 2014 9:15 PM Flag

    Make that September 2017. They can be selling in October - Using Shire manufactured product.

    Sentiment: Strong Buy

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.